In a hospital corridor at 2 a.m., the loudest sound used to be a janitor's auto-scrubber. Increasingly, in facilities served by Aramark, that machine is driving itself. Pringle Robotics, a Peoria, Illinois company founded in 2022, says its autonomous floor cleaners are now working through more than 16 million square feet of commercial floor every day, and have cumulatively cleaned more than 2 billion square feet to date [Pringle Robotics, 2025]. For a four-year-old hardware company with a solo founder and no disclosed venture round, that is an unusually large physical footprint.
The patient population here is not a clinical cohort, but it matters all the same: the people who walk those floors. In healthcare settings, floor hygiene is tied directly to healthcare-associated infection risk, and the standard of care today still leans heavily on human environmental services staff using manual mops and ride-on or walk-behind auto-scrubbers from incumbents like Tennant Company and Nilfisk Group. Disinfection protocols for high-touch surfaces typically rely on quaternary ammonium or bleach wipes, with UV-C devices deployed in terminal cleans of operating rooms and isolation rooms. Robotic floor care, where it exists, is usually a Brain Corp-powered scrubber retrofitted onto an existing chassis. Pringle is trying to sit inside that workflow rather than replace it.
The bet
Pringle's wedge is not a single robot but a small catalog aimed at facilities managers who are already short on labor. The lineup includes autonomous floor scrubbers, a 360-degree UV-C and ultrasonic dry-mist disinfection robot described as medical grade, a secure delivery robot for office and clinical environments, and an interactive guide robot for lobbies and visitor check-in [USAClean, retrieved 2026]. The company sells these into hospitality, healthcare, and retail buyers, and pitches the economics in straightforward labor-substitution terms. In a distributor interview published on the company's blog, a school district customer was told the math worked out to a payback period of under two years against labor savings on a single machine [Pringle Robotics].
That framing matters because the buyer is rarely a CIO or a chief medical officer. It is a director of environmental services or a regional facilities lead, often working through a contracted services provider. This is where the most consequential relationship in the Pringle story comes in.
Why it could be big
In June 2024, Aramark announced a partnership to deploy Pringle's autonomous floor cleaning robots across its facilities business [Aramark, June 2024]. By August 2025, Aramark was reporting that the deployment was cleaning 50 million square feet annually [Aramark, August 2025]. Aramark serves hospitals, universities, stadiums, and corporate campuses, exactly the high-traffic, labor-constrained environments where autonomous cleaning has the clearest return. A single named channel partner of that scale is the kind of distribution a seed-stage hardware company normally spends years trying to earn.
The broader tailwind is real. Commercial cleaning labor has been structurally short since 2021, wages have risen, and hospital systems in particular have been pushed to document environmental hygiene more rigorously. Brain Corp, Avidbots, and Squad Robotics are all chasing the same opening, and the legacy equipment makers Tennant and Nilfisk are increasingly shipping autonomy as a feature rather than a separate product [CB Insights]. Pringle's claim is that owning the full stack across cleaning, disinfection, delivery, and guest interaction lets a facility standardize on one vendor for a building's robot fleet. If that thesis holds, the addressable spend is not just floor care, it is a meaningful slice of the facilities management budget.
Cumulative sq ft cleaned (Pringle, 2025) | 2000 | M sq ft
Daily run rate (Pringle, 2025) | 16 | M sq ft
Aramark annual deployment (Aramark, Aug 2025) | 50 | M sq ft
The team and traction
Pringle is led by founder and CEO Sudheer Sajja, who holds a BE in Computer Science and Engineering from the University of Madras (1996 to 2000) and has additional coursework associated with Dakota State University [The Org, retrieved 2026; AeroLeads, retrieved 2026]. The company employs a chief technology officer with a product development team reporting in [LinkedIn, retrieved 2026]. The Aramark relationship is the most externally verifiable piece of momentum, and it has been corroborated by Aramark's own investor communications and by trade press [Nasdaq; IoT Evolution World]. The cumulative cleaning milestone, by contrast, is company-disclosed and was first staged publicly in January 2025 when Pringle announced it had crossed 1 billion square feet [PRNewswire, January 2025], with the 2 billion figure following later in the year.
The honest counterfactual
What the bears say: this is a category where Brain Corp has a multi-year head start with a software-only model that runs on hardware from Tennant, Nilfisk, Minuteman, and others, and where Avidbots has built a focused franchise around its Neo scrubber. A solo-founder seed-stage company with no disclosed institutional round faces real questions about how it funds the working capital cycle that hardware-plus-services demands at scale [CB Insights]. What the bulls answer: Pringle is not trying to win on the cleaning robot alone. The Aramark channel gives it a distribution path the pure-play robotics competitors have not publicly matched, and the broader product line (UV-C disinfection, delivery, guest hosting) gives a single facility multiple reasons to standardize on one vendor. If even a fraction of Aramark's facilities footprint converts to a multi-robot deployment, the unit economics look quite different from a one-scrubber-at-a-time sale.
What to watch
The next twelve months should clarify three things. First, whether Pringle discloses an institutional funding round, the cleaning footprint it is now claiming is hard to support indefinitely on undisclosed capital. Second, whether the Aramark relationship expands beyond floor care into disinfection, which would be the more clinically meaningful deployment in hospital settings and would invite scrutiny under FDA rules governing UV-C devices marketed for infection control. Third, whether any peer-reviewed or independently audited data emerges on cleaning efficacy and infection-rate outcomes in the healthcare sites where the robots are deployed. Hardware traction is the easier story to tell. For a robot that shares a corridor with immunocompromised patients, the outcomes data is the one that will matter.
Pulse Raman, Health and Bio Correspondent, Startuply.